Our Founders and Advisors
We are a group of research, commercialization, brand, and marketing experts dedicated to launching advanced technologies out of research labs and into the marketplace.
Founder Michael Crowley is a serial entrepreneur, venture capitalist, M&A professional and investment banker with strong personal track-record in business and start-up funding. He is an avid researcher, educator and seasoned speaker.
Erin C. Crowley Ellis
Erin Crowley brings deep quality management experience to all ATVentureCenter startup businesses. She has solved many systemic production and quality problems in manufacturing, including at Toyota.
Dr. Omar Aljitawi
Dr. Omar Aljitawi, M.B.B.S. is a practicing oncologist and Associate Professor of Hematology/Oncology at the University of Rochester’s Department of Medicine. He is an authority on human hematopoietic stem cells.
Todd has guided business transformations and achieved sustainable success in a broad range of markets including medical devices, professional services, telecommunications, manufacturing and logistics.
Frank Razavi, MBA, MSc., has over 18 years experience in corporate, university, and startup settings, managing large technology projects, technology investment commercialization/licensing, and new venture creation.
Stephen Morse is a serial entrepreneur, foreign correspondent, dot-com founder and global marketing professional who served as Director of Communications for Xerox Services, a $2.2 billion company.
Dr. Ajay Kajay
Dr. Ajay Kashi, BDS, DDS, PhD is a passionate researcher and inventor who holds several patents in the area of biomedical engineering and medical devices. He works in a busy dental practice and has published extensively.
Michael Higgins, MBA, MSF is a distinguished veteran and senior executive with over 23 years of experience leading diverse teams and solving challenging cross-organizational problems..
Dr. Ian Wilson
Dr. Ian Wilson is the founder of the first practice in the Rochester region dedicated to the evaluation and treatment of peripheral vascular disease (from claudication to critical limb ischemia) and venous disease.